Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder

2018238 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT02651584.

Good health and well-being

Published in: JAMA Internal Medicine

Volume 178, Issue 6, pp. 764-764

Field-Weighted Citation Impact: 20.22